For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Akebia Therapeutics Inc (NASDAQ: AKBA) closed at $1.80 down -5.76% from its previous closing price of $1.91. In other words, the price has decreased by -$5.76 from its previous closing price. On the day, 3.98 million shares were traded.
Ratios:
For a deeper understanding of Akebia Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.21 and its Current Ratio is at 1.52.
On August 28, 2023, H.C. Wainwright Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.75.
Piper Sandler Upgraded its Neutral to Overweight on May 31, 2023, whereas the target price for the stock was revised from $2 to $4.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 03 ’25 when Butler John P. sold 144,250 shares for $2.10 per share. The transaction valued at 302,925 led to the insider holds 2,604,330 shares of the business.
Burke Steven Keith sold 50,506 shares of AKBA for $106,063 on Feb 03 ’25. The SVP, Chief Medical Officer now owns 816,234 shares after completing the transaction at $2.10 per share. On Feb 03 ’25, another insider, Malabre Richard C, who serves as the SVP, Chief Accounting Officer of the company, sold 30,202 shares for $2.10 each. As a result, the insider received 63,424 and left with 280,248 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.31.
Stock Price History:
Over the past 52 weeks, AKBA has reached a high of $2.48, while it has fallen to a 52-week low of $0.80. The 50-Day Moving Average of the stock is -10.77%, while the 200-Day Moving Average is calculated to be 16.23%.
Shares Statistics:
A total of 211.54M shares are outstanding, with a floating share count of 209.46M. Insiders hold about 4.00% of the company’s shares, while institutions hold 28.71% stake in the company.
